Abstract: Self-calcifying, self-replicating nanoparticles have been isolated from calcifi ed human tissues. However, it is unclear if these nanoparticles participate in disease processes. Therefore, this study was designed to preliminarily test the hypothesis that human-derived nanoparticles are causal to arterial disease processes. One carotid artery of 3 kg male rabbits was denuded of endothelium; the contralateral artery remained unoperated as a control. Each rabbit was injected intravenously with either saline, calcifi ed, or decalcifi ed nanoparticles cultured from calcifi ed human arteries or kidney stones. After 35 days, both injured and control arteries were removed for histological examination. Injured arteries from rabbits injected with saline showed minimal, eccentric intimal hyperplasia. Injured arteries from rabbits injected with calcifi ed kidney stone-and arterial-derived nanoparticles occluded, sometimes with canalization. The calcifi ed kidney stone-derived nanoparticles caused calcifi cations within the occlusion. Responses to injury in rabbits injected with decalcifi ed kidney stone-derived nanoparticles were similar to those observed in saline-injected animals. However, decalcifi ed arterial-derived nanoparticles produced intimal hyperplasia that varied from moderate to occlusion with canalization and calcifi cation. This study offers the fi rst evidence that there may be a causal relationship between human-derived nanoparticles and response to injury including calcifi cation in arteries with damaged endothelium.
Introduction
Self-replicating, self calcifying nanoparticles (NPs, formerly called nanobacteria) ranging in size of 0.08-0.5 µm which form a biofi lm containing carbonate or hydroxylapatite have been isolated and propagated from mammalian blood (Kajander et al 1997) and calcifi ed human arterial tissue and kidney stones (Miller et al 2004; Shiekh et al 2006) . Although the exact nature of these nano-sized particles remains controversial, their propagation is reduced by certain antibiotics and inhibitors of oxidative metabolism (Bjorklund et al 1998; Ciftcioglu et al 2002; Kumar et al 2006) . They incorporate radiolabeled uridine and phosphate into their structures and some sequences of nucleic acids have been isolated from biofi lms containing nanosized structures (Kajander et al 1997; Cisar et al 2000; Miller et al 2004; Kumar et al 2006) . Propagation seems to be accelerated in environments simulating microgravity (Ciftcioglu et al 2005) .
In addition to calcifi ed renal and arterial tissue, similar structures are found in human urine, renal cyst fl uid (Ciftcioglu et al 2002) , capsules from breast implants (Deva and Chang 1999) , prostatitis (Shoskes et al 2005) , gall stones (Wang et al 2006) , dental plaque (Ciftcioglu et al 2003) , intestinal tissue affected by infl ammatory bowel disease (Meissner et al 2006) , and ovarian cancer (Sedivy and Battistutti 2003) . In spite of these associations, a cause and effect relationship between NPs and disease pathogenesis remains unclear. Therefore, in order to show a causal relationship between human-derived NPs and disease, Koch's postulates dictate that particles (organisms) must be identifi ed in diseased tissue, isolated and propagated from diseased tissue, and inoculation of an animal with the isolates should recapitulate the disease. Therefore, this pilot study was designed to test the hypothesis that inoculation of naïve animals with different preparations of self-replicating, self-calcifying, human-derived NPs would initiate disease processes, specifi cally arterial calcifi cation, in rabbits.
Methods

Nanoparticle culture and collection
Self-replicating, self calcifying NPs derived from human calcifi ed aortic aneurysms and kidney stones (Miller et al 2004) were used in these experiments. NPs for injection were isolated from mature cultures which had formed a characteristic biofi lm of calcifi ed domes adhering to the bottom of polystyrene culture fl asks. Culture fl asks contained Dulbecco's Modified Eagle Medium (DMEM 10-013, Mediatech Inc, Manassas, VA) supplemented with 50 µM beta-mercaptoethanol (Sigma Chemical Co, St. Louis, MO), 10% γ-irradiated fetal calf serum (Atlanta Biologicals Inc, Lawrenceville, GA), and CaCl 2 (Sigma) to 3.6 mM.
Calcifi ed human-derived NPs were collected by gently washing 10 confl uent fl asks twice with 10 ml sterile phosphatebuffered saline (PBS). The fl asks were scraped to loosen NP colonies from the fl ask and the scrapings collected and centrifuged (20 min, 4 °C, 20,000 g). After each spin, tubes were consolidated in 0.5 ml PBS and centrifuged again. Once all pellets had been consolidated to a single tube, the pellet was washed twice with Tris buffer (10 mM) and the fi nal pellet was suspended in 1 ml sterile saline for injection into the animal.
Decalcifi ed human-derived NPs were collected by gently washing 3 confl uent fl asks twice with 10 ml sterile PBS containing 0.5 M ethylendiaminetetraacetic acid (EDTA) and then adding 1 ml of 0.5 M EDTA to the fl asks for 1 h. The fl asks were then scraped and the resulting solution was centrifuged (30 min, 4 °C, 60,000 g). Pellets were consolidated, washed, and re-suspended as described above for the calcifi ed NPs. NPs ranged in size from 50-200 nm and in some situations formed clumps (please see Miller et al 2004) .
Animals and surgery
Adult male (3 kg) New Zealand white rabbits (n = 9 total) were fed LabDiet hi-fi ber rabbit chow ad libitum and were maintained in individual cages (12 hr light/12 hr dark cycle). Once animals were inoculated with NPs, they were maintained in a Biohazard Level 2 safety facility. All protocols were approved by the Animal Care and Use Committee and Biosafety Committee of the Mayo Clinic.
The left carotid artery of each animal was denuded of endothelium using balloon injury. Briefl y, animals were sedated intramuscularly using a mixture of ketamine (35 mg/kg, Ketaset, Fort Dodge Animal Health, Fort Dodge, IA), xylazine (5 mg/kg, VetTek, Blue Springs, MO) and acepromazine (1 mg/kg, Boehringer Ingelheim Vetmedica Inc, St. Joseph, MO). They received a prophylactic dose of 0.25 ml penicillin (Pen-aqueous, Durvet, Inc., Blue Springs, MO) IM to reduce infection related to the surgery. This antibiotic does not interfere with NP replication in culture (Ciftcioglu et al 2002) . Saline (60 ml, 0.9% NaCl, Baxter Healthcare Corp, Deerfi eld, IL) was administered subcutaneously to prevent dehydration during the surgery. Using universal aseptic techniques, the left carotid artery was exposed and mobilized by gentle blunt dissection through a ventral midline incision in the neck. Small side branches were exposed and cauterized at least 5 mm away from the common carotid. Heparin (Baxter Healthcare Corp, Deerfi eld, IL) was administered (1000 U/kg) through a catheter in the marginal ear vein. The carotid artery was then temporarily occluded proximally and distally with microvascular clamps.
Monofi lament suture (8-0 Ethilon; Ethicon, Somerville, NJ) was used to create a purse string suture in the anterior region of the occluded artery. A 3.0 French Fogarty (Edwards Lifesciences, Irvine, CA) angioplasty catheter was introduced into the lumen through a small incision made in the center of the purse-string suture. The balloon was infl ated until the artery was distended to 150%. The catheter was withdrawn and advanced three times in order to denude the endothelium. The incision was closed with the purse-string suture. The injured area was marked by placing one small suture at the distal end of the artery where the balloon had been extended. The vascular clamps were then removed. The remaining carotid artery was not exposed, serving as the unoperated contralateral control. The surgical site was closed in three layers, the fi nal closure being a subcuticular stitch so that the animal could not chew the sutures.
Inoculation
While still under anesthesia, and within 3 hrs after the surgery, animals were injected with one of the following solutions (total volume of inoculant and saline washes was 5 ml) via a catheter placed in the marginal ear vein: 1. Saline (Control; n = 2). This group was the standard for the healing response. 2. Calcifi ed arterial-derived nanoparticles derived from 10 fl asks (n = 1). 3. Calcifi ed kidney stone-derived nanoparticles derived from 10 fl asks (n = 1). 4. Decalcifi ed arterial-derived nanoparticles derived from three fl asks (n = 3). 5. Decalcifi ed kidney stone-derived nanoparticles derived from three fl asks (n = 2).
Tissue collection
At 35 days post-operative, animals were anesthetized and carotid arteries were removed, fi xed in formalin, embedded in paraffin, sectioned, and examined histologically. Adjacent sections (5 micron) from each artery were evaluated by light microscopy for general anatomical features such as intima:media ratio, presence of a fi brous cap, and calcifi cation using elastin van Giesen, hematoxylin and eosin, and von Kossa stains, respectively. Slides were viewed on an Axioplan 2 upright microscope equipped with a Plan-Neofl uar 5×, 0.15 na objective lens (Zeiss, Thornwood, NY). Images were digitized with an AxioCam HRc camera (Zeiss) mounted to the microscope with a 0.63 × c-mount and interfaced through KS400 image analysis software (Zeiss). Lumen, intima, and media borders were interactively selected and the intimal and medial areas were calculated with the KS400 software.
Histological analysis
The extent of myointimal hyperplasia was evaluated based on intima:media ratios and a qualitative analysis of the condition of the internal elastic lamina and media in arterial cross-sections. One section per stain was evaluated from each animal (three sections/animal).
Results
All animals remained in good health throughout the study and none showed anorexia or signs of neurological defi cits (eye drooping, immobility, etc). The uninjured artery from all rabbits in all groups showed normal anatomy with a single layer of endothelial cells, intact internal elastic lamina and media, and an adventitia devoid of infl ammatory cells (Figure 1, upper left panel) . The injured artery of animals injected with saline showed eccentric intimal hyperplasia (Figure 1 , upper right panel); the intima:media ratios for the injured arteries from the two animals injected with saline were 0.39 and 1.33. The lumen of the injured artery of each rabbit inoculated with calcifi ed arterial-or kidney-stone-derived NPs was fi lled with acellular and cellular material which was canalized with blood vessels. The media layer lost cohesion even though the internal elastic lamina remained intact (Figure 1 ; middle panels).
The extent of vascular healing and intimal hyperplasia in injured carotid arteries of rabbits injected with decalcifi ed arterial-derived NPs was variable. In one animal, there was minimal intimal hyperplasia consistent with that observed in the injured arteries of animals injected with saline ( Figure 2 , left panel). The art ery from another rabbit inoculated with decalcifi ed arterial-derived NPs had greater myointimal hyperplasia than observed in saline-injected animals and the internal elastic lamina was discontinuous (Figure 2 , middle panel). In the third rabbit injected with decalcifi ed arterial-derived NPs, the denuded artery occluded (with canalization) and a plaque, which stained positive for calcium phosphate, formed along the intima-medial border where the internal elastic lamina was disrupted ( 
Discussion
Results of this study, while preliminary, provide the fi rst evidence of a causal relationship between human-derived NPs and arterial disease processes including accelerated development of intimal hyperplasia and calcification. Evidence has been published to support a causal relationship between NPs and black pigment gall stones (Wang et al 2006) and renal lithogenesis (Ciftcioglu et al 2005; Shiekh et al 2006) . However, the gall stone study utilized direct injection of NPs into the target organ. Intravenous injection of kidney-derived NPs localized to the kidney in the nephrolithiasis study (Shiekh et al 2006) . The present study extends these observations to demonstrate that an intravenous injection of kidney stone-and arterial-derived 
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NPs accelerates a pathological process initiated by other stimuli, in this case, mechanical endothelial denudation. This systemic exposure to NPs might be comparable to that resulting from an environmental exposure as could occur in humans. The systemic route of administration, and perhaps an immune response to the NPs, may explain some of the variability in the vascular healing response observed in animals inoculated with the human-derived NPs. Whether NPs would accelerate the response to vascular injury caused by other means, ie, endothelial dysfunction due to hyperlipidemia, remains to be determined.
Variability in vascular responses in animals exposed to human-derived NPs may also have resulted from the way inoculants were prepared. Calcifi ed NPs were derived from combined scrapings of biofi lm from 10 fl asks and, even with several washing of the scraped biofi lm, some proteins in the culture media may remain adhered to hydroxyapatite shells of the NPs, initiating an immune response. Future experiments could investigate the contribution of inorganic hydroxyapatite as a carrier of mitogenic proteins and stimuli of infl ammation (Nadra et al 2008) .
To eliminate the potential contribution of the hydroxyapatite shell, NPs were decalcifi ed. However, variability in vascular remodeling was still evident. Thus, the response to injury observed in NP-inoculated animals does not appear to be mediated only by the calcium phosphate shell and/or nonspecifi cally associated proteins.
These experiments have several shortcomings. First, the number of animals in this pilot study was small. However, there were clear differences in responses of animals injected with saline compared with those injected with NPs and the intimal hyperplasia in saline-injected rabbits was comparable with that seen in other studies of endothelial damage in rabbits (Orlandi et al 2002) , rats (Chen and Mehta 1996) , and pigs (Shimokawa et al 1989) . Second, the inoculant was not standardized beyond using material initially derived from the same number of culture fl asks. This method does not take into account differences in the quality of the cultures or number of viable NP colonies in each fl ask. Differences in NP preparations could account for some of the variability in responses among animals. In the future, methods to standardize inoculants need to be developed including evaluating responses to free fl oating, "planktonic" NPs rather than those isolated from established biofi lm. Furthermore, complete removal of the hydroxyapatite shell from the decalcifi ed NPs could not be verifi ed using the current process. Therefore, reliable methods of isolating or producing uncalcifi ed NPs must be developed. Finally, it is not known whether inoculated animals developed an immune-type response to the NPs that would be comparable to that of animals exposed to other infectious agents (eg, Chlamydia pneumonia cytomegalovirus) implicated in arterial disease (Mattila et al 1993; Muhlestein 1998; Epstein et al 2000; Burnett et al 2001; Muhlestein and 
Anderson 2003)
. Future experiments will need to explore the immunological responses evoked by NPs.
In spite of these short comings, results of this study provide exciting proof-of-principle that human-derived, selfreplicating, self-calcifying NPs accelerate vascular wound healing and may lead to pathological calcifi cation. Although the exact chemical, physical and biological nature of these human-derived NPs remains to be elucidated (Martin et al 1965; Miller et al 2004; Benzerara et al 2006) , these results support the need for ongoing investigation of the medical and pathophysiological consequences of NPs in humans. Regardless of whether or not NPs represent a pleiotropic form of bacteria or biofi lm (Domingue and Schlegel 1977; Akerman et al 1993; Domingue and Woody 1997; Costerton et al 1999; Cisar et al 2000; Vali et al 2001) , the cumulative evidence from this and other studies (Shiekh et al 2006; Wang et al 2006) suggest that human-derived NPs participate in disease processes. Even if NPs are ultimately found not to be a life form in the classic sense, these experiments suggest a novel mechanism of disease propagation, namely that endogenous or exogenously derived calcifi ed NPs can deliver pathogenic factors to a diseased segment of vessel and stimulate atherogenesis. Determining when and how humans may be exposed to these particles and the interindividual variability in response to such an exposure could signify a paradigm shift in the diagnosis and treatment of some diseases, including arterial calcifi cation.
